Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors
Clinical trial NCT05320640 · UNKNOWN
Trial details
- NCT number
- NCT05320640
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-30
- Primary completion
- 2024-04-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.